Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for Renal Function After Kidney Transplant
NCT00425698Phase 3Completed
- Sponsor
- Hannover Medical School
- Start
- Feb 2007
- Primary completion
- May 2009
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in ischemia-reperfusion injury (IRI), sponsored by Hannover Medical School. Started Feb 2007; status: completed.
02
Drugs
epoetin alfa
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00425698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425698.